A decade of cerebrospinal fluid biomarkers for Alzheimer’s disease in Belgium

Manuscript Number: 

15-1097R2

Author(s): 
Maria Bjerke, Patrick Cras, Peter Paul De Deyn, Ellen De Roeck, Naomi De Roeck, Bart De Vil, Sebastiaan Engelborghs, Joery Goossens, Jill Luyckx, Jean-Jacques Martin, Ellis Niemantsverdriet, Charisse Somers, Hanne Struyfs

Disclosures

Maria Bjerke

  • Nothing to Disclose

Patrick Cras

  • Consulting Fees:
    in the past year, I contributed to an advisory board of Abbie and was remunerated 750€
    Lecture Fees:
    I received 500€ for a lecture for Teva and identical amount from Zambon

Peter Paul De Deyn

  • Nothing to Disclose

Ellen De Roeck

  • Nothing to Disclose

Naomi De Roeck

  • Nothing to Disclose

Bart De Vil

  • Nothing to Disclose

Sebastiaan Engelborghs

  • Consulting Fees:
    Paid advisory boards: Nutricia / Danone
    Grants
    • Agency: 
      Janssen Pharmaceutica
      Dates: 
      1 OCT 2015 -
    • Agency: 
      ADx NeuroSciences
      Dates: 
      1 OCT 2016 -

Joery Goossens

  • Nothing to Disclose

Jill Luyckx

  • Nothing to Disclose

Jean-Jacques Martin

  • Nothing to Disclose

Ellis Niemantsverdriet

  • Nothing to Disclose

Charisse Somers

  • Nothing to Disclose

Hanne Struyfs

  • Nothing to Disclose